Rory B. Riggs - 16 Nov 2021 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Jason Mehar, as Attorney-in-Fact for Rory B. Riggs
Issuer symbol
RPRX
Transactions as of
16 Nov 2021
Net transactions value
-$9,076,492
Form type
4
Filing time
18 Nov 2021, 18:15:16 UTC
Previous filing
04 Oct 2021
Next filing
30 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Other +4,674 +0.74% 636,060 16 Nov 2021 Direct F1, F2
transaction RPRX Class A Ordinary Shares Other +61,338 +9.6% 697,398 16 Nov 2021 Direct F2, F3
transaction RPRX Class A Ordinary Shares Sale $527,805 -12,565 -1.8% $42.01 684,833 16 Nov 2021 Direct F4
transaction RPRX Class A Ordinary Shares Other -219,710 -28% 569,782 16 Nov 2021 By New Ventures Select F5
transaction RPRX Class A Ordinary Shares Other -1,028,973 -35% 1,888,385 16 Nov 2021 By New Ventures I LLC F6
transaction RPRX Class A Ordinary Shares Other -612,668 -35% 1,146,986 16 Nov 2021 By New Ventures III LLC F7
transaction RPRX Class A Ordinary Shares Sale $2,646,401 -62,435 -9.1% $42.39 622,398 17 Nov 2021 Direct F8
transaction RPRX Class A Ordinary Shares Sale $2,931,900 -69,233 -12% $42.35 500,549 17 Nov 2021 By New Ventures Select F9
transaction RPRX Class A Ordinary Shares Sale $1,643,749 -38,815 -2.1% $42.35 1,849,570 17 Nov 2021 By New Ventures I LLC F9
transaction RPRX Class A Ordinary Shares Sale $1,326,636 -31,341 -2.7% $42.33 1,115,645 17 Nov 2021 By New Ventures III LLC F10
holding RPRX Class A Ordinary Shares 15,000 16 Nov 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution from New Ventures Select, of which the Reporting Person has voting and investment control.
F2 Pro rata distribution from a limited liability company of which the Reporting Person is a member.
F3 Pro rata distribution from New Ventures I LLC, of which the Reporting Person has voting and investment control.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.06 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.
F6 New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.
F7 New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.
F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.90 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.50 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.97 to $42.50 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.